newsfilter
← Latest News
ClinicalTrials.gov·

Composur: Study to Understand the Performance of Vibegron in Participants With Overactive Bladder (OAB) - NCT05067478

Mean Satisfaction Domain Score as Assessed by the Overactive Bladder Satisfaction with Treatment Questionnaire (OAB-SAT-q), Percentage of Positive Responders to Individual Treatment Satisfaction Questions 1-3 and 11 as Assessed by the OAB-SAT-q, Mean Scores on the Side Effects, Endorsement, Convenience, and Preference Domains as Assessed by the OAB-SAT-q, (and 3 more...)